Treatment of the gastrointestinal tract with dimeric naphthalimide compounds
US12295949B2 · kind B2 · utility
0Cited by
9References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2022 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Jan 11, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for treating stenosis in the digestive system and conditions associated with irregular esophageal tone with dimeric naphthalimide compounds and their pharmaceutically acceptable salts. Also disclosed are methods for enhancing recovery following esophageal surgery that entail treatment of the surgical area with dimeric naphthalimide compounds and their pharmaceutical salts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.